drugset / Trial / NCT02235402

A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients

NCT02235402

Phase 4 Completed 26 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to compare the effects of lacidipine on markers of platelet activation and other rheological factors in hypertensive patients with those of bendrofluazide

Timeline

Start
1997-12
Primary completion
2000-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bendroflumethiazide Small molecule
Subject Lacidipine Small molecule

Indications